NR AQVO
AU Louie,J.K.; Gavali,S.S.; Belay,E.D.; Trevejo,R.; Hammond,L.H.; Schonberger,L.B.; Vugia,D.J.
TI Barriers to Creutzfeldt-Jakob disease autopsies, California
QU Emerging Infectious Diseases 2004 Sep; 10(9): 1677-80
IA http://www.cdc.gov/ncidod/EID/vol10no9/04-0066.htm
PT journal article
AB Creutzfeldt-Jakob disease (CJD) surveillance relies on autopsy and neuropathologic evaluation. The 1990-2000 CJD autopsy rate in California was 21%. Most neurologists were comfortable diagnosing CJD (83%), but few pathologists felt comfortable diagnosing CJD (35%) or performing autopsy (29%). Addressing obstacles to autopsy is necessary to improve CJD surveillance.
MH *Autopsy/statistics & numerical data; California/epidemiology; Creutzfeldt-Jakob Syndrome/*diagnosis/epidemiology; Data Collection; Health Knowledge, Attitudes, Practice; Humans; Neurology; Pathology; Physicians; Population Surveillance
AD Janice K. Louie (jlouie@dhs.ca.gov), Shilpa S. Gavali, Lucinda H. Hammond, Duc J. Vugia, California Emerging Infections Program, Richmond, California, USA; Janice K. Louie, Rosalie Trevejo, Duc J. Vugia, California Department of Health Services, Berkeley, California, USA; Ermias D. Belay, Lawrence B. Schonberger, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
SP englisch
PO USA
EA HTML-Version und pdf-Datei